ATE497776T1 - Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren - Google Patents
Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahrenInfo
- Publication number
- ATE497776T1 ATE497776T1 AT03799982T AT03799982T ATE497776T1 AT E497776 T1 ATE497776 T1 AT E497776T1 AT 03799982 T AT03799982 T AT 03799982T AT 03799982 T AT03799982 T AT 03799982T AT E497776 T1 ATE497776 T1 AT E497776T1
- Authority
- AT
- Austria
- Prior art keywords
- hypertensive
- production
- peg chains
- reacting
- bound
- Prior art date
Links
- 102000001554 Hemoglobins Human genes 0.000 title abstract 3
- 108010054147 Hemoglobins Proteins 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 abstract 1
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 1
- CNHYKKNIIGEXAY-UHFFFAOYSA-N thiolan-2-imine Chemical compound N=C1CCCS1 CNHYKKNIIGEXAY-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43614902P | 2002-12-23 | 2002-12-23 | |
| PCT/US2003/040407 WO2004058291A1 (en) | 2002-12-23 | 2003-12-18 | Modified hemoglobin and methods of making same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE497776T1 true ATE497776T1 (de) | 2011-02-15 |
Family
ID=32682349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03799982T ATE497776T1 (de) | 2002-12-23 | 2003-12-18 | Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7501499B2 (de) |
| EP (1) | EP1585538B1 (de) |
| JP (1) | JP2006514652A (de) |
| KR (1) | KR101086138B1 (de) |
| CN (1) | CN1741812B (de) |
| AT (1) | ATE497776T1 (de) |
| AU (1) | AU2003299700B2 (de) |
| BR (1) | BR0317721A (de) |
| CA (1) | CA2511494A1 (de) |
| DE (1) | DE60336018D1 (de) |
| ES (1) | ES2360215T3 (de) |
| MX (1) | MXPA05006702A (de) |
| MY (1) | MY135256A (de) |
| SA (1) | SA04250032B1 (de) |
| TW (1) | TW200505941A (de) |
| WO (1) | WO2004058291A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030153491A1 (en) * | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| EP1894573A3 (de) * | 2002-01-11 | 2013-06-12 | Sangart, Inc. | Verfahren und Zusammensetzungen für den Sauerstofftransport mit hoher Sauerstoffaffinität |
| US7144989B2 (en) | 2002-03-25 | 2006-12-05 | Albert Einstein College Of Medicine Of Yeshiva University | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof |
| US7521174B2 (en) * | 2003-12-05 | 2009-04-21 | Albert Einstein College Of Medicine Of Yeshiva University | Universal red blood cells, methods of preparing same, and uses thereof |
| KR20070069154A (ko) * | 2004-08-31 | 2007-07-02 | 생가트, 인코포레이티드 | 산소 운반 조성물을 사용하여 혈역학적 안정성을향상시키는 방법 |
| US20060134694A1 (en) * | 2004-12-22 | 2006-06-22 | Intel Corporation | Methods of protein profiling by thiolation |
| CA2600927C (en) | 2005-03-07 | 2017-04-18 | Sangart, Inc. | Compositions and methods for delivering carbon monoxide (co) and nitric oxide (no) to tissue using heme proteins as carriers |
| WO2007050121A2 (en) * | 2005-05-11 | 2007-05-03 | Albert Einstein College Of Medicine Of Yeshiva University | Site specific pegylated hemoglobin, method of preparing same, and uses thereof |
| WO2006135740A1 (en) * | 2005-06-10 | 2006-12-21 | Albert Einstein College Of Medicine Of Yeshiva University | Pegylated hemoglobin and albumin and uses thereof |
| WO2007058678A2 (en) | 2005-06-10 | 2007-05-24 | Albert Einstein College Of Medicine Of Yeshiva University | Uses of pegylated albumin |
| US7795401B2 (en) * | 2006-09-06 | 2010-09-14 | National Chung Cheng University | Modified hemoglobin with allosteric effector conjugated |
| US8697645B2 (en) * | 2007-03-13 | 2014-04-15 | Albert Einstein College Of Medicine Of Yeshiva University | Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders |
| CN101306196B (zh) * | 2008-07-03 | 2011-05-11 | 中国科学院长春应用化学研究所 | 一种生物降解的键合了血红蛋白分子的纳米粒子及制法 |
| US10172950B2 (en) | 2009-06-09 | 2019-01-08 | Prolong Pharmaceuticals, LLC | Hemoglobin compositions |
| US10172949B2 (en) | 2009-06-09 | 2019-01-08 | Prolong Pharmaceuticals, LLC | Hemoglobin compositions |
| ES2966234T3 (es) | 2009-06-09 | 2024-04-18 | Prolong Pharmaceuticals Llc | Composiciones de hemoglobina |
| AU2011220885A1 (en) * | 2010-02-25 | 2012-09-06 | Sangart, Inc. | Methods for preparing PEG-hemoglobin conjugates using reduced reactant ratios |
| US7989593B1 (en) | 2010-05-27 | 2011-08-02 | Bing Lou Wong | Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
| US7932356B1 (en) | 2010-06-23 | 2011-04-26 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
| US8048856B1 (en) | 2010-06-23 | 2011-11-01 | Billion King, Ltd. | Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition |
| US8084581B1 (en) | 2011-04-29 | 2011-12-27 | Bing Lou Wong | Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus |
| US20130052232A1 (en) | 2011-08-31 | 2013-02-28 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
| CN104379160A (zh) | 2012-03-29 | 2015-02-25 | 桑加特公司 | 双阿司匹林交联聚乙二醇化血红蛋白 |
| JP2015514718A (ja) | 2012-04-03 | 2015-05-21 | サンガート, インコーポレイテッド | スクシンイミド活性化されたニトロキシル化合物およびタンパク質のニトロキシル化のためのその使用のための方法 |
| US10821158B2 (en) | 2013-03-15 | 2020-11-03 | William Schindler | Polyalkylene oxide valerate hemoglobin conjugates |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234903A (en) * | 1989-11-22 | 1993-08-10 | Enzon, Inc. | Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute |
| US5585484A (en) * | 1995-04-19 | 1996-12-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Hemoglobin crosslinkers |
| US5900402A (en) * | 1997-05-29 | 1999-05-04 | Enzon, Inc. | Method of reducing side effects associated with administration of oxygen-carrying proteins |
| US6773613B1 (en) * | 1998-10-15 | 2004-08-10 | Sangart, Inc. | Method for production of stroma-free hemoglobin |
| US7019117B2 (en) * | 2001-07-19 | 2006-03-28 | Albert Einstein College Of Medicine Of Yeshiva University | Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols |
| EP1469811A4 (de) * | 2002-01-11 | 2006-01-04 | Sangart Inc | Verfahren und zusammensetzungen für den sauerstofftransport mit modifiziertem hämoglobin in plasma |
| US20030153491A1 (en) * | 2002-01-11 | 2003-08-14 | Winslow Robert M. | Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| US7144989B2 (en) * | 2002-03-25 | 2006-12-05 | Albert Einstein College Of Medicine Of Yeshiva University | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof |
| US7521174B2 (en) * | 2003-12-05 | 2009-04-21 | Albert Einstein College Of Medicine Of Yeshiva University | Universal red blood cells, methods of preparing same, and uses thereof |
| WO2007050121A2 (en) | 2005-05-11 | 2007-05-03 | Albert Einstein College Of Medicine Of Yeshiva University | Site specific pegylated hemoglobin, method of preparing same, and uses thereof |
-
2003
- 2003-12-18 KR KR1020057011737A patent/KR101086138B1/ko not_active Expired - Fee Related
- 2003-12-18 AU AU2003299700A patent/AU2003299700B2/en not_active Ceased
- 2003-12-18 MX MXPA05006702A patent/MXPA05006702A/es active IP Right Grant
- 2003-12-18 ES ES03799982T patent/ES2360215T3/es not_active Expired - Lifetime
- 2003-12-18 JP JP2004563778A patent/JP2006514652A/ja active Pending
- 2003-12-18 EP EP03799982A patent/EP1585538B1/de not_active Expired - Lifetime
- 2003-12-18 US US10/538,976 patent/US7501499B2/en not_active Expired - Fee Related
- 2003-12-18 BR BR0317721-1A patent/BR0317721A/pt not_active IP Right Cessation
- 2003-12-18 CN CN2003801091578A patent/CN1741812B/zh not_active Expired - Fee Related
- 2003-12-18 DE DE60336018T patent/DE60336018D1/de not_active Expired - Lifetime
- 2003-12-18 CA CA002511494A patent/CA2511494A1/en not_active Abandoned
- 2003-12-18 WO PCT/US2003/040407 patent/WO2004058291A1/en not_active Ceased
- 2003-12-18 AT AT03799982T patent/ATE497776T1/de not_active IP Right Cessation
- 2003-12-22 MY MYPI20034947A patent/MY135256A/en unknown
- 2003-12-23 TW TW092136572A patent/TW200505941A/zh unknown
-
2004
- 2004-03-09 SA SA04250032A patent/SA04250032B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006514652A (ja) | 2006-05-11 |
| CN1741812A (zh) | 2006-03-01 |
| US7501499B2 (en) | 2009-03-10 |
| MY135256A (en) | 2008-03-31 |
| US20060135753A1 (en) | 2006-06-22 |
| ES2360215T3 (es) | 2011-06-01 |
| SA04250032B1 (ar) | 2007-07-31 |
| CN1741812B (zh) | 2013-04-24 |
| WO2004058291A1 (en) | 2004-07-15 |
| DE60336018D1 (de) | 2011-03-24 |
| KR101086138B1 (ko) | 2011-11-25 |
| AU2003299700B2 (en) | 2009-03-26 |
| EP1585538A4 (de) | 2007-11-21 |
| AU2003299700A1 (en) | 2004-07-22 |
| BR0317721A (pt) | 2005-12-06 |
| MXPA05006702A (es) | 2005-09-30 |
| KR20050084460A (ko) | 2005-08-26 |
| EP1585538B1 (de) | 2011-02-09 |
| TW200505941A (en) | 2005-02-16 |
| CA2511494A1 (en) | 2004-07-15 |
| EP1585538A1 (de) | 2005-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE497776T1 (de) | Nicht-hypertensive pegylierte hämoglobine und deren herstellungsverfahren | |
| ATE369878T1 (de) | Träger-pharmaka-konjugate | |
| WO1998001158A3 (de) | Hämoglobin-hydroxyethylstärke-konjugate als sauerstoff-transport-mittel | |
| ZA200606237B (en) | Bicycloester derivative | |
| MXPA03009840A (es) | Derivados de fenilurea sustituidos con carboxamida y metodo para la produccion de los mismos como farmacos. | |
| CY1114922T1 (el) | Κυτταροτοξικοι παραγοντες οι οποιοι περιλαμβανουν νεα παραγωγα τομαϋμυκινης και τη θεραπευτικη τους χρηση | |
| EP2292636A3 (de) | Prozess, um Antikörper und therapeutische Produkte zu konzentrieren | |
| EA200800657A1 (ru) | Способ приготовления очищенных конъюгатов лекарственных средств | |
| FI942075A0 (fi) | Sappihappojohdannaisten tetratsolijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina | |
| WO2002008190A3 (de) | Neue heteroaryl-derivate und deren verwendung als antitumormittel | |
| WO2004078797A8 (en) | Macromolecular ketoaldehydes | |
| WO2008076270A3 (en) | Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof | |
| ATE372984T1 (de) | Benzoylpyridin-derivate oder deren salze, diese als aktive komponente enthaltende fungizide, herstellungsverfahren und zwischenprodukte für ihre herstellung | |
| AU1922902A (en) | Novel means for the diagnosis and therapy of CTCL | |
| TW200716179A (en) | Transglutaminase mediated conjugation of growth hormone | |
| ATE421535T1 (de) | Peg-modifiziertes erythropoietin | |
| BR0214884A (pt) | Derivados de 7-amino-benzotiazol como ligantes do receptor de adenosina | |
| EP1988090A4 (de) | Imidazol-5-carbonsäurederivate, herstellungsverfahren und verwendung davon | |
| WO2008016682A3 (en) | Aryl vinyl sulfides, sulfones, sulfoxides and sulfonamides, derivatives thereof and therapeutic uses thereof | |
| ATE541558T1 (de) | Photoaktivierbare zusammensetzung und ihre verwendung | |
| DE60021305D1 (de) | Verfahren zur Herstellung von Diaminodiphenylmethan und seiner höheren Homologen | |
| DK1557387T3 (da) | Transportorgan med en ledkæde og klemmer | |
| EP1907419A4 (de) | Herstellung von insulinkonjugaten | |
| ATE446952T1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
| ATE382371T1 (de) | Bifunktionale derivate von polyethylenglykol, ihre herstellung und verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |